Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $4.48 + 0.20 (4.67%)
Today's Open$4.24
Previous Close$4.28
Data as of 09/21/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $4.48 with a 52 week high of $13.96 and a 52 week low of $2.60.
Recent News

August 30, 2017

NantHealth and Asia Genomics Announce Global Expansion of GPS CancerTM in Southeast Asia

Partnership enables oncologists in Singapore, Malaysia, Thailand, Vietnam and The Philippines to offer patients a new standard of care through GPS Cancer NantHealth expands global GPS Cancer launch with test now also internationally available in Israel, Mexico, Italy and the Middle East CULVER CITY, Calif. & SINGAPORE--(BUSINESS WIRE)--Aug. 30, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced that it has ente...

Read More >

August 10, 2017

NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial Intelligence for Cancer Care

Restructuring Plan Implemented To Focus on Cancer Decision Support and Artificial Intelligence Platform Integration of Four Pillars: GPS Cancer, Eviti Clinical Decision Support, Connected Care and Provider/Payer Engagement Sale of Patient/Provider Portal to Allscripts Expected to Significantly Accelerate Timeline to Profitability ...

Read More >

August 08, 2017

NantHealth to Report 2017 Second-Quarter Financial Results and Host Conference Call on Thursday, August 10

CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 second quarter on Thursday, August 10, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will...

Read More >

Upcoming Events
There are currently no events scheduled.